HOYA Co. (OTCMKTS:HOCPY - Get Free Report) saw a large decline in short interest in April. As of April 15th, there was short interest totalling 3,000 shares, a decline of 26.8% from the March 31st total of 4,100 shares. Based on an average daily volume of 154,900 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the company's stock are sold short.
HOYA Stock Performance
Shares of HOCPY stock opened at $116.96 on Thursday. The company's 50-day moving average is $113.34 and its 200 day moving average is $124.68. The company has a market capitalization of $40.45 billion, a price-to-earnings ratio of 29.76, a price-to-earnings-growth ratio of 2.38 and a beta of 0.90. HOYA has a one year low of $97.49 and a one year high of $148.27. The company has a debt-to-equity ratio of 0.02, a quick ratio of 4.35 and a current ratio of 5.04.
HOYA (OTCMKTS:HOCPY - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The technology company reported $0.95 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.94. HOYA had a net margin of 24.17% and a return on equity of 21.34%. Sell-side analysts expect that HOYA will post 3.66 EPS for the current fiscal year.
About HOYA
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HOYA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HOYA wasn't on the list.
While HOYA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
